Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

YOUTUBE LIVE “SIMPOSIO INTERNACIONAL” – STIMULAN / 10 NOV – México 17:00 (CMT)

YouTube LIVE SIMPOSIO INTERNACIONAL Martes 10 de…

Dormir menos de 8 horas puede dañar tu corazón: esto necesitas saber

Dormir las horas adecuadas es fundamental para…

Superbugs will kill 10 million a year if drugmakers sit on hands, WHO warns

If the government does not incentivize…

New resistance-busting antibiotic combination could extend the use of ‘last-resort’ antibiotics

Science Daily recently published an article on…

A novel protein therapy for efficient skin wound healing

A group of researchers at A*STAR’s (Agency for…

La resistencia a los antibióticos puede extenderse en ausencia de medicamentos.

Medical News Today informó recientemente sobre…

La contaminación plástica puede estar extendiendo la resistencia a los antibióticos

Según una nueva investigación, compartida por la…

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Global burden of bacterial antimicrobial…

National Diabetes Foot Care Report

National Diabetes Foot Care Report The National…